Preventive neck dissection for squamous cell carcinoma of the lower lip
DOI: 10.32364/2587-6821-2025-9-7-2
M.A. Rustamzade, N.M. Amiraliev
Azerbaijan Medical University, Baku, Azerbaijan
Background: squamous cell carcinoma (SCC) is the most common histological type of malignancy affecting the lower lip. In cases of carcinoma at this site, the most significant diagnostic factor is the status of regional cervical metastases. Although surgery remains the treatment of choice, the use of prophylactic neck dissection in the absence of clinically detectable metastases remains a matter of ongoing debate.
Aim: to assess the efficacy of prophylactic neck dissection in cases of clinically negative (cN0) lymph nodes in lower lip SCC.
Patients and Methods: this retrospective study included 85 patients diagnosed with lower lip SCC, classified as T1-4N0M0 according to the American Joint Committee on Cancer (AJCC). Of these, 51 patients underwent prophylactic neck dissection (study group) at a single institution between 2008 and 2023, while 34 patients did not undergo selective neck dissection (follow-up group) following primary tumor resection. Patients were evaluated with regard to the size of the primary tumor and the type of prophylactic neck dissection performed, based on risk and nodal status.
Results: among the operated patients, regional metastases were identified in 14 (27.4%) cases. Prophylactic supraomohyoid (levels I–III) neck dissection was performed in 39 (76.5%) patients, with nodal metastases detected in 11 (28.2%) of them. Among patients who underwent anterolateral neck dissection (levels I–IV), this finding was observed in 3 (25.0%) cases.
Conclusion: lower lip SCC is characterized by a relatively favorable prognosis; however, regional lymph node metastasis significantly worsens survival outcomes. The present results support the selective use of prophylactic neck dissection for T1–2N0 lower lip SCC in patients with high-risk patterns and its routine performance in all cases of stage T3–4N0M0 disease to prevent regional metastatic spread. Taking risk factors into account, we advocate for supraomohyoid (levels I–III) neck dissection in cN0 patients with high-risk lower lip carcinoma.
Keywords: lower lip tumors, squamous cell carcinoma, neck dissection.
For citation: Rustamzade M.A., Amiraliev N.M. Preventive neck dissection for squamous cell carcinoma of the lower lip. Russian Medical Inquiry. 2025;9(7):382–386 (in Russ.). DOI: 10.32364/2587-6821-2025-9-7-2
About the authors:
Mehriban A. Rustamzade — Doctoral Candidate of the Department of Oncology, Faculty of Medicine, Azerbaijan Medical University; 108, S. Vurgun str., Baku, Azerbaijan; ORCID iD 0009-0000-1956-8403
Namik M. Amiraliev — Dr. Sc. (Med.), Professor, Department of Oncology, Faculty of Medicine, Azerbaijan Medical University; 108, S. Vurgun str., Baku, Azerbaijan; ORCID iD 0009-0001-3960-8393
Contact information: Mehriban A. Rustamzade, e-mail: dr.abdullayeva.nco@gmail.com
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 30.09.2024.
Revised 23.10.2024.
Accepted 15.11.2024.
2. Czerninski R., Zini A., Sgan-Cohen H.D. Lip cancer: incidence, trends, histology and survival: 1970–2006. Br J Dermatol. 2010;162(5):1103–1109. DOI: 10.1111/j.1365-2133.2010.09698.x
3. Hoffman H.T., Karnell L.H., Funk G.F. et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124(9):951–962. DOI: 10.1001/archotol.124.9.951
4. Wiser I., Scope A., Azriel D. et al. Head and Neck Cutaneous Squamous Cell Carcinoma Clinicopathological Risk Factors according to Age and Gender: A Population-based Study. Isr Med Assoc J. 2016;18(5):275–278. PMID: 27430083
5. Zitsch R.P. 3rd, Park C.W., Renner G.J., Rea J.L. Outcome analysis for lip carcinoma. Otolaryngol Head Neck Surg. 1995;113(5):589–596. DOI: 10.1177/019459989511300510
6. Bucur A., Stefanescu L. Management of patients with squamous cell carcinoma of the lower lip and N0-neck. J Craniomaxillofac Surg. 2004;32(1):16–18. DOI: 10.1016/j.jcms.2003.08.007
7. Zitsch R.P. 3rd, Lee B.W., Smith R.B. Cervical lymph node metastases and squamous cell carcinoma of the lip. Head Neck. 1999;21(5):447–453. DOI: 10.1002/(sici)1097-0347(199908)21:5<447::aid-hed11>3.0.co;2-r
8. Yilmaz S., Ercocen A.R. Is elective neck dissection in T1-2, N0 patients with lower lip cancer necessary? Ann Plast Surg. 2009;62(4):381–383. DOI: 10.1097/SAP.0b013e318184ab14
9. Алымов Ю.В., Нодвязников С.О., Мудунов А.М. К вопросу о селективных шейных лимфодиссекциях в терапии рака слизистой оболочки полости рта. Современная онкология. 2016;18(1):75–79. Alymov Yu.V., Podvyaznikov S.O., Mudunov A.M. Concerning selective neck dissections in oral squamous cell carcinoma. Journal of Modern Oncology. 2016;18(1):75–79 (in Russ.).
10. Babington S., Veness M.J., Cakir B. et al. Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision? ANZ J Surg. 2003;73(8):621–625. DOI: 10.1046/j.1445-2197.2003.t01-1-02710.x
11. De Visscher J.G., Botke G., Schakenraad J.A., van der Waal I. A comparison of results after radiotherapy and surgery for stage I squamous cell carcinoma of the lower lip. Head Neck. 1999;21(6):526–530. DOI: 10.1002/(sici)1097-0347(199909)21:6<526::aid-hed5>3.0.co;2-b
12. Edge S.B., Compton C.C. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol. 2010;17:1471–1474. DOI: 10.1245/s10434-010-0985-4
13. Silistreli O., Ayhan M., Kilic M. et al. The role and criterias of head ang neck region: 5 years experience. Turk Plast Reconst. Est Cer Derg. 2003;11:172–176.
14. Виноградов И.Ю. Клинико-морфологические факторы прогноза при раке нижней губы и их влияние на результаты лечения: дис. … канд. мед. наук. Рязань; 2003. Vinogradov I.Yu. Clinical and morphological prognostic factors for cancer of the lower lips and their influence on treatment results: thesis. Ryazan, 2003 (in Russ.).
15. Schmults C.D., Blitzblau R., Aasi S.Z. et al. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022. J Natl Compr Canc Netw. 2021;19(12):1382–1394. DOI: 10.6004/jnccn.2021.0059
16. Ciloglu N., Yesildali K., Zeytin K. Lower lip cancer treatment and reconstruction options: a retrospective evaluation of 51 patients. Haydarpaşa Numune Med J. 2013;53(3):136–140.
17. Kuscu O., Bajin M.D., Süslü N., Hoşal A.Ş. The role of suprahyoid neck dissection in the treatment of squamous cell carcinoma of the lower lip: 20 years' experience at a Tertiary Center. J Craniomaxillofac Surg. 2016;44(9):1404–1407. DOI: 10.1016/j.jcms.2016.06.004
18. Shah J.P., Patel S.G., Bhuvanesh S., Wong R. Jatin Shah's Head and Neck Surgery and Oncology. 4th ed. Philadelphia, PA: Elsevier/Mosby, 2012.
19. Teichgraeber J.F., Clairmont A.A. The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale. Head Neck Surg. 1984;7(1):15–21. DOİ: 10.1002/hed.2890070105
20. Califano L., Zupi A., Massari P.S., Giardino C. Lymph-node metastasis in squamous cell carcinoma of the lip. A retrospective analysis of 105 cases. Int J Oral Maxillofac Surg. 1994;23(6 Pt 1):351–355. DOİ: 10.1016/s0901-5027(05)80053-0
21. Cantu G., Chiesa F., Molinari R. Risultati della terapia della diffusione linfatica del carcinoma del labbro e della commessura labiale. Nuovo Arch İtal Otol. 1977;5:483–488.
22. Connolly K.L., Nehal K.S., Disa J.J. Evidence-Based Medicine: Cutaneous Facial Malignancies: Nonmelanoma Skin Cancer. Plast Reconstr Surg. 2017;139(1):181e–190e. DOI: 10.1097/PRS.0000000000002853
23. Gooris P.J., Vermey A., De Visscher J.G. et al. Supraomohyoid neck dissection in the management of cervical lymph node metastases of squamous cell carcinoma of the lower lip. Head Neck. 2002;24(7):678–683. DOI: 10.1002/hed.10079
24. Kutluhan A., Kiriş M., Kaya Z. et al. Squamous cell carcinoma of the lower lip and supra-omohyoid neck dissection. Acta Chir Belg. 2003;103(3):304–308. DOI: 10.1080/00015458.2003.11679429
25. Wein R., Malone J.P., Weber R.S. Malignant Neoplasms of the Oral Cavity In book: Cummings Otolaryngology — Head and Neck Surgery. 2010;1293–1318. DOI: 10.1016/B978-0-323-05283-2.00097-5
26. Koç A., Acipaym H., Koçak H. et al. Our clinical approach to lip cancer: surgery and reconstruction principles. Okmeydanı Tıp dergisi. 2017;33:139–143. DOI: 10.5222/otd.2017.1112
27. Alkureishi L.W., Ross G.L., Shoaib T. et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol. 2010;17(9):2459–2464. DOI: 10.1245/ s10434-010-1111-3
28. De Visscher J.G., van den Elsaker K., Grond A.J. et al. Surgical treatment of squamous cell carcinoma of the lower lip: evaluation of long-term results and prognostic factors-a retrospective analysis of 184 patients. J Oral Maxillofac Surg. 1998;56(7):814–820; discussion 820–821. DOI: 10.1016/s0278-2391(98)90001-5
29. Hosal I.N., Onerci M., Kaya S., Turan E. Squamous cell carcinoma of the lower lip. Am J Otolaryngol. 1992;13(6):363–365. DOI: 10.1016/0196-0709(92)90077-7
30. Sollamo E.M., Ilmonen S.K., Virolainen M.S., Suominen S.H. Sentinel lymph node biopsy in cN0 squamous cell carcinoma of the lip: A retrospective study. Head Neck. 2016;38 Suppl 1:E1375–1380. DOI: 10.1002/hed.24230
31. Gershenwald J.E., Ross M.I. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med. 2011;364(18):1738–1745. DOI: 10.1056/NEJMct1002967
32. Benson J.R., della Rovere G.Q.; Axilla Management Consensus Group. Management of the axilla in women with breast cancer. Lancet Oncol. 2007;8(4):331–348. DOI: 10.1016/S1470-2045(07)70103-1
This work is licensed under a Creative Commons «Attribution» 4.0 License.
